Release Date: 22/10/19 08:27 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 617.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%